These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33155205)

  • 1. The role of PIAS3, p-STAT3 and ALR in colorectal cancer: new translational molecular features for an old disease.
    Polimeno L; Francavilla A; Piscitelli D; Fiore MG; Polimeno R; Topi S; Haxhirexha K; Ballini A; Daniele A; Santacroce L
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10496-10511. PubMed ID: 33155205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
    Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
    Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
    Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
    Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A positive feedback loop between miR-181b and STAT3 that affects Warburg effect in colon cancer via regulating PIAS3 expression.
    Pan X; Feng J; Zhu Z; Yao L; Ma S; Hao B; Zhang G
    J Cell Mol Med; 2018 Oct; 22(10):5040-5049. PubMed ID: 30054984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
    Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
    Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenter of liver regeneration (ALR) exhibits a dual signaling impact on hepatic acute-phase response.
    Dayoub R; Buerger L; Ibrahim S; Melter M; Weiss TS
    Exp Mol Pathol; 2017 Jun; 102(3):428-433. PubMed ID: 28506765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
    Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
    Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
    Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
    Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy.
    Yang SF; Hou MF; Chen FM; Ou-Yang F; Wu YC; Chai CY; Yeh YT
    BMC Cancer; 2016 Jan; 16():20. PubMed ID: 26768588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
    Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
    Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-543 inhibits proliferation and metastasis of human colorectal cancer cells by targeting PLAS3.
    Su DW; Li X; Chen J; Dou J; Fang GE; Luo CJ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8812-8821. PubMed ID: 32964969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples.
    Gatzidou E; Mantzourani M; Giaginis C; Giagini A; Patsouris E; Kouraklis G; Theocharis S
    J BUON; 2015; 20(1):84-91. PubMed ID: 25778301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway.
    Li C; Wang R; Zhang Y; Hu C; Ma Q
    Mol Med; 2021 Nov; 27(1):150. PubMed ID: 34837964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
    Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
    Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of STAT3 NH
    Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
    Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Formylchromone inhibits proliferation and induces apoptosis of multiple myeloma cells by abrogating STAT3 signaling through the induction of PIAS3.
    Ko JH; Ho Baek S; Nam D; Chung WS; Lee SG; Lee J; Mo Yang W; Um JY; Seok Ahn K
    Immunopharmacol Immunotoxicol; 2016 Oct; 38(5):334-43. PubMed ID: 27324722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
    Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
    Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.